GLUD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.038200E-01
Normal-vs-Stage2
9.118200E-01
Normal-vs-Stage3
2.999600E-01
Normal-vs-Stage4
3.631600E-01
Stage1-vs-Stage2
4.092600E-01
Stage1-vs-Stage3
7.658100E-02
Stage1-vs-Stage4
5.024600E-01
Stage2-vs-Stage3
2.283200E-01
Stage2-vs-Stage4
1.079240E-01
Stage3-vs-Stage4
9.562100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.504000E-01
Normal-vs-AfricanAmerican
4.886600E-01
Normal-vs-Asian
6.909000E-01
Caucasian-vs-AfricanAmerican
1.979760E-01
Caucasian-vs-Asian
3.437400E-01
AfricanAmerican-vs-Asian
1.507030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.883200E-01
Normal-vs-Female
9.931400E-01
Male-vs-Female
5.784800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.988600E-01
Normal-vs-Age(41-60Yrs)
6.198400E-01
Normal-vs-Age(61-80Yrs)
8.604600E-01
Normal-vs-Age(81-100Yrs)
8.706600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.694800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.234000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.018800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.129990E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.496400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.694600E-01
Normal-vs-Daily Drinker
8.872600E-01
Normal-vs-Weekly Drinker
6.799000E-01
Normal-vs-Occasional Drinker
5.003800E-01
Normal-vs-Social Drinker
7.982600E-01
Non Drinker-vs-Daily Drinker
9.185600E-01
Non Drinker-vs-Weekly Drinker
6.332200E-01
Non Drinker-vs-Occasional Drinker
5.746100E-02
Non Drinker-vs-Social Drinker
9.809600E-01
Daily Drinker-vs-Weekly Drinker
6.806400E-01
Daily Drinker-vs-Occasional Drinker
1.141980E-01
Daily Drinker-vs-Social Drinker
9.455600E-01
Weekly Drinker-vs-Occasional Drinker
6.697700E-02
Weekly Drinker-vs-Social Drinker
6.853800E-01
Occasional Drinker-vs-Social Drinker
9.181800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.269650E-01
Normal-vs-Grade 2
4.839800E-02
Normal-vs-Grade 3
1.867630E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.220000E-01
Grade 1-vs-Grade 3
2.495900E-02
Grade 1-vs-Grade 4
1.269650E-01
Grade 2-vs-Grade 3
1.310960E-01
Grade 2-vs-Grade 4
4.839800E-02
Grade 3-vs-Grade 4
1.867630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.989600E-01
Normal-vs-NonDiabetic
8.956600E-01
Diabetic-vs-NonDiabetic
6.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.510400E-01
Normal-vs-NoPancreatitis
9.869400E-01
Pancreatitis-vs-NoPancreatitis
3.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.443800E-01
Normal-vs-N1
9.148800E-01
N0-vs-N1
8.907800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.175400E-01
Normal-vs-TP53-NonMutant
9.452800E-01
TP53-Mutant-vs-TP53-NonMutant
1.432830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
